Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-07

Clinical Trial Update: Oxytocin Treatment of Opioid Dependence [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on oxytocin treatment for opioid dependence and withdrawal.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Opioid Dependence, Opioid Withdrawal | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-08-07